| 000 | 01743 a2200505 4500 | ||
|---|---|---|---|
| 005 | 20250518041449.0 | ||
| 264 | 0 | _c20200203 | |
| 008 | 202002s 0 0 eng d | ||
| 022 | _a1476-5551 | ||
| 024 | 7 |
_a10.1038/s41375-019-0476-y _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aJain, Tania | |
| 245 | 0 | 0 |
_aSafety and feasibility of chimeric antigen receptor T cell therapy after allogeneic hematopoietic cell transplantation in relapsed/ refractory B cell non-Hodgkin lymphoma. _h[electronic resource] |
| 260 |
_bLeukemia _c10 2019 |
||
| 300 |
_a2540-2544 p. _bdigital |
||
| 500 | _aPublication Type: Letter; Research Support, N.I.H., Extramural | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aB-Lymphocytes _ximmunology |
| 650 | 0 | 4 | _aFeasibility Studies |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aHematopoietic Stem Cell Transplantation _xmethods |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImmunotherapy, Adoptive _xadverse effects |
| 650 | 0 | 4 |
_aLymphoma, B-Cell _ximmunology |
| 650 | 0 | 4 |
_aLymphoma, Non-Hodgkin _ximmunology |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aNeoplasm Recurrence, Local _ximmunology |
| 650 | 0 | 4 |
_aReceptors, Chimeric Antigen _ximmunology |
| 700 | 1 | _aSauter, Craig S | |
| 700 | 1 | _aShah, Gunjan L | |
| 700 | 1 | _aMaloy, Molly A | |
| 700 | 1 | _aChan, Jason | |
| 700 | 1 | _aScordo, Michael | |
| 700 | 1 | _aAvecilla, Scott T | |
| 700 | 1 | _aBatlevi, Yakup | |
| 700 | 1 | _aDahi, Parastoo B | |
| 700 | 1 | _aBatlevi, Connie W | |
| 700 | 1 | _aLia Palomba, M | |
| 700 | 1 | _aGiralt, Sergio A | |
| 700 | 1 | _aPerales, Miguel-Angel | |
| 773 | 0 |
_tLeukemia _gvol. 33 _gno. 10 _gp. 2540-2544 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1038/s41375-019-0476-y _zAvailable from publisher's website |
| 999 |
_c29715078 _d29715078 |
||